# Quantitative Insights, Inc.

- Location (FDA's records): Chicago, IL
- FDA decisions: 2 (2017–2017): 1 510(k) clearance and 1 De Novo grant
- Product codes: POK (1), LLZ (1)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 5 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Confirma, Inc.: 2 (https://510kreport.com/company/confirma)

## Firms that cite its devices most
- Ischemaview, Inc.: 1 (https://510kreport.com/company/ischemaview)
- Koios Medical, Inc.: 1 (https://510kreport.com/company/koios-medical)
- Avenda Health, Inc.: 1 (https://510kreport.com/company/avenda-health)
- Optellum, Ltd.: 1 (https://510kreport.com/company/optellum)
- Taihao Medical, Inc.: 1 (https://510kreport.com/company/taihao-medical)

## Its most-cited devices
- DEN170022: QuantX (2017), cited by 4
- K170195: QuantX (2017), cited by 1

## Recent decisions
- DEN170022: QuantX (Jul 19, 2017)
- K170195: QuantX (May 17, 2017)

Source page: https://510kreport.com/company/quantitative-insights